• Explore /
  • Poster
  • / NOGGO Ov-42/MAMOC: Rucaparib maintenance after bevacizumab maintenance following carboplatin-based first line-chemotherapy in ovarian cancer patients.

NOGGO Ov-42/MAMOC: Rucaparib maintenance after bevacizumab maintenance following carboplatin-based first line-chemotherapy in ovarian cancer patients.

Abstract Poster

Authors

null

Elena Ioana Braicu

Department of Gynecology, Charité Medical University, Berlin, Germany

Elena Ioana Braicu , Pauline Wimberger , Rolf Richter , Maren Keller , Petra Krabisch , Mustafa Deryal , Ingo B. Runnebaum , Ralf Witteler , Nikola Bangemann , Frederik Marmé , Michael Eichbaum , Florian Heitz , Barbara Schmalfeldt , Eva Egger , Dorothea Fischer , Radoslav Chekerov , Jacek P. Grabowski , Jalid Sehouli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT04227522

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS6102)

DOI

10.1200/JCO.2020.38.15_suppl.TPS6102

Abstract #

TPS6102

Poster Bd #

273

Abstract Disclosures

Similar Posters

First Author: Vaibhav Sahai

First Author: Florian Heitz

First Author: Jinan Liu

First Author: Elena Ioana Braicu